logo
logo

B2B Saas Startup Leucine Raises $7 Million In Funding Led By Ecolab

Oct 16, 2023•over 1 year ago

Amount Raised

$7 Million

New YorkMachine LearningArtificial IntelligenceBiotechnologyManufacturingAnalytics

Description

Leucine, a business-to-business startup servicing software for pharmaceutical companies in India and the United States, on Monday said it has raised $7 million in a Series A funding round led by Ecolab.New York Stock Exchange-listed Ecolab is a Minnesota-based company that provides water, hygiene and infection prevention solutions and services.Other investors included Pravega Ventures, Axilor Ventures, Techstars and angel investors. Leucine cofounder and CEO Vivek Gera told ET that the company will prioritise building its go-to-market (GTM) motion, ramp up AI capabilities and expand the team over the next two-three quarters. The software-as-a-service startup, with offices in Jersey City and Bengaluru, helps its pharmaceutical manufacturing clients with batch planning to batch release, modernising traditional procedures and replacing paper-based records with a digital-first approach.Powered ByVideo Player is loading.Play VideoPlaySkip BackwardMuteCurrent Time 0:00/Duration 0:00Loaded: 0%Stream Type LIVESeek to live, currently behind liveLIVERemaining Time -0:00 1xPlayback RateChaptersChaptersDescriptionsdescriptions off, selectedCaptionscaptions and subtitles off, selectedAudio TrackPicture-in-PictureFullscreenThis is a modal window.No compatible source was found for this media.Beginning of dialog window. Escape will cancel and close the window.TextColorWhiteBlackRedGreenBlueYellowMagentaCyanOpacityOpaqueSemi-TransparentText BackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanOpacityOpaqueSemi-TransparentTransparentCaption Area BackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanOpacityTransparentSemi-TransparentOpaqueFont Size50%75%100%125%150%175%200%300%400%Text Edge StyleNoneRaisedDepressedUniformDropshadowFont FamilyProportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall CapsReset restore all settings to the default valuesDoneClose Modal DialogEnd of dialog window.AdvertisementA batch execution procedure is the single most important document in pharma manufacturing, Gera said, adding that Leucine’s digitisation capability reduces the cycle of a batch record from 6-8 months to 3-5 days.Discover the stories of your interestBlockchain5 StoriesCyber-safety7 StoriesFintech9 StoriesE-comm9 StoriesML8 StoriesEdtech6 StoriesThe platform also helps clients with actionable insights through an artificial intelligence-driven analytics dashboard.The company has also announced a beta launch of Leucine10x, an AI-powered framework designed to serve as a co-pilot in pharmaceutical manufacturing processes."Our models are trained on a wealth of pharma data, which allows the platform to create custom workflows enriched with GxP compliance measures, enabling us to deliver unparalleled value at breakneck speed," Gera said.The company was founded by Gera and Mustaq Singh Bijral in 2019

Company Information

Company

Leucine

Location

16 WILLOW AVENUE

New York, New York, United States

About

Leucine is an AI-powered platform that helps pharmaceutical manufacturers in staying compliant and audit-ready while ensuring their medicines reach the patients faster. Using Leucine, the Manufacturing, QA, and QC teams can significantly increase productivity and reduce deviations from cGMP guidelines across thousands of complex regulated workflows from material receipt to batch release. Leucine supports manufacturers across all modalities such as small molecules, biologics, gene therapies, vaccines etc. We have built industry's first AI framework, Leucine10x, which is designed to serve as a co-pilot in pharmaceutical manufacturing processes. Built on proprietary LLM technology, Leucine 10X offers an army of AI co-pilots that perform highly specialized tasks such as digitizing paper-based SOPs, creating a digital twin of the shop floor, collaborating with Production Managers in creating dynamic production plans, thus ensuring on-time batch delivery. Most significant is its ability to speed up Root Cause Analysis (RCA) of deviations in the manufacturing process by quickly analyzing data, including text-based records, logs, and even staff interview transcripts, to identify potential issues or patterns that might not be readily apparent. Leucine is currently deployed at over 30 companies in over 300 pharma manufacturing facilities across 10 countries, including the US, India, Brazil, Mexico, UAE, and others. Our customers trust us in helping them deliver safe medicine in the hands of the patients across the world. For more information visit: https://www.leucine.io

Related People